NASDAQ : CYAD

Celyad Oncology S.A.

$0.47 USD

-$0.07 (-12.96%)

Volume
49K
Average Volume
18.58K
Market Capitalization
$14.24M
P/E Ratio
-2.93
Dividend Yield
0.00%
Price Target
Year High
$3.07
Year Low
$0.15
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.79
Source Headline

Get CYAD Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

CYAD Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

CYAD Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2022-01-11 Wells Fargo Maintain Overweight Overweight
2021-08-06 HC Wainwright & Co. Maintain Buy Buy
2021-05-10 HC Wainwright & Co. Maintain Buy Buy
2021-03-26 JonesTrading Downgrade Buy Hold
2020-12-08 HC Wainwright & Co. Maintain Buy Buy
2020-03-26 Wells Fargo Maintain Overweight Overweight
2020-03-25 H.C. Wainwright Maintain Buy Buy
2016-07-05 UBS Downgrade Buy Neutral
2015-08-26 UBS Maintain Buy Buy